McKesson Corporation Common Stock (MCK)
Industrials › Wholesale-Drugs, Proprietaries & Druggists' Sundries
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- P/E of 23.3 — elevated valuation multiple
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 21,614.3% — good return on equity
- Revenue growing at 12% annually
McKesson Corporation Common Stock (MCK) is a Industrials company operating in Wholesale-Drugs, Proprietaries & Druggists' Sundries, listed on the NYSE , with a market capitalisation of $92.1 billion . Key value metrics: P/E ratio 23.3, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
McKesson Corporation Common Stock — Fundamental Analysis Summary
McKesson Corporation Common Stock (MCK) trades at a trailing P/E of 23.3x — 14% below the Industrials sector average of 26.9x.
On financial health, MCK shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 21,614.3% (sector average: 4.9%).
StockPik's composite Value Score for MCK is 60/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MCK reports a thin gross margin of 3.4% (sector average: 46.3%) and a modest operating margin of 1.3%.
MCK shows revenue growing at 12% year-over-year, with earnings growing at 45%.
MCK pays a modest dividend yield of 0.4%.